ZEROCUF AM (Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml))
-15%

ZEROCUF AM (Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml))

Original price was: ₹73.10.Current price is: ₹62.40.

Placeholder

Original price was: ₹73.10.Current price is: ₹62.40.

Add to cart
Buy Now
Category: Tag:

ZEROCUF AM SYP is a liquid formulation commonly used to help manage symptoms associated with cough and respiratory discomfort. It is particularly helpful for those experiencing issues related to mucus production and throat irritation. By combining multiple active ingredients, this syrup aims to provide relief from coughing while also supporting easier breathing.

The active ingredients in ZEROCUF AM SYP work together in a complementary manner. Ambroxol helps in thinning mucus, making it easier to cough up. Guaifenesin serves to further loosen mucus in the airways, aiding in its expulsion. Menthol provides a soothing effect on the throat and can create a sensation of easier breathing. Terbutaline acts as a bronchodilator, relaxing the muscles in the airways to help improve airflow.

For optimal use, store ZEROCUF AM SYP in a cool, dry place away from direct sunlight. Consistency in use may enhance its effectiveness, so it is advisable to follow the guidance provided by your healthcare professional regarding its application. Always ensure the cap is tightly closed after each use to maintain the syrup’s quality.

Some common, mild side effects may include nausea, dizziness, or a dry mouth. While these effects are generally not serious, if they persist or worsen, it is important to seek advice from a healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.

Reviews

There are no reviews yet.

Be the first to review “ZEROCUF AM (Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml))”

Your email address will not be published. Required fields are marked *

Top